Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Mitglied/er, Klinik für Knochenmarktransplantation
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Hope for motherhood : Pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)In: Blood, Jg. 144, 2024, Nr. 14, S. 1532 – 1542DOI (Open Access)
-
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis : updated recommendations by the EBMT/ELN International Working GroupIn: The Lancet Haematology, Jg. 11, 2024, Nr. 1, S. e62 – e74DOI, Online Volltext (Open Access)
-
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation : a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMTIn: The Lancet Haematology, Jg. 10, 2023, Nr. 1, S. e59 – e70
-
Chimärismusanalyse nach Stammzelltransplantation mit hochsensitiven MethodenIn: Transfusionsmedizin, Jg. 12, 2022, Nr. 04, S. 227 – 232
-
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisIn: Blood Advances, Jg. 6, 2022, Nr. 4, S. 1222 – 1231DOI (Open Access)
-
Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse : best practice recommendations of the EBMT Chronic Malignancies Working PartyIn: Leukemia, Jg. 35, 2021, Nr. 9, S. 2445 – 2459DOI, Online Volltext (Open Access)
-
Comparison of cytomegalovirus-specific immune cell response to proteins versus peptides using an ifn-γ elispot assay after hematopoietic stem cell transplantationIn: Diagnostics, Jg. 11, 2021, Nr. 2, 312DOI (Open Access)
-
Correction: Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse : Best practice recommendations of the EBMT Chronic Malignancies Working PartyIn: Leukemia, 2021, in pressDOI (Open Access)
-
Humoral and cellular vaccination responses against sars-cov-2 in hematopoietic stem cell transplant recipientsIn: Vaccines, Jg. 9, 2021, Nr. 10, 1075DOI (Open Access)
-
Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic LeukemiaIn: Transplantation and Cellular Therapy, Jg. 27, 2021, Nr. 1, S. 95.e1 – 95.e4DOI (Open Access)
-
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantationIn: Haematologica / The Hematology Journal, Jg. 106, 2021, Nr. 2, S. 363 – 374DOI (Open Access)
-
Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host diseaseIn: Blood, Jg. 137, 2021, Nr. 17, S. 2403 – 2416DOI (Open Access)
-
Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignanciesIn: American Journal of Transplantation, Jg. 20, 2020, Nr. 3, S. 677 – 688DOI (Open Access)
-
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutationIn: European Journal of Haematology, Jg. 103, 2019, Nr. 6, S. 552 – 557
-
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease : Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and SwitzerlandIn: Biology of Blood and Marrow Transplantation, Jg. 25, 2019, Nr. 7, S. 1450 – 1455DOI (Open Access)
-
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantationIn: Blood, Jg. 133, 2019, Nr. 20, S. 2233 – 2242DOI (Open Access)
-
Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCRIn: Journal of Clinical Virology, Jg. 99-100, 2018, S. 61 – 66DOI (Open Access)
-
Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host diseaseIn: Bone Marrow Transplantation, Jg. 53, 2018, Nr. 9, S. 1149 – 1156
-
High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemiaIn: British Journal of Haematology, Jg. 180, 2018, Nr. 6, S. 840 – 853
-
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsIn: Nature Medicine, Jg. 24, 2018, Nr. 3, S. 282 – 291DOI (Open Access)
-
Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantationIn: European Journal of Cancer (EJC), Jg. 86, 2017, S. 233 – 239
-
CD34+ highly enriched allogeneic stem cell transplantation in a patient with mixed phenotype acute leukemia and Fusarium solani sepsisIn: Annals of Hematology, Jg. 95, 2016, Nr. 1, S. 155 – 156
-
Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-DiseaseIn: Digestive Diseases and Sciences, Jg. 61, 2016, Nr. 7, S. 2019 – 2026
-
Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosisIn: Blood, Jg. 125, 2015, Nr. 21, S. 3347 – 3350DOI (Open Access)
-
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis : a consensus process by an EBMT/ELN international working groupIn: Leukemia, Jg. 29, 2015, Nr. 11, S. 2126 – 2133
-
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation : a multicenter surveyIn: Leukemia, Jg. 29, 2015, Nr. 10, S. 2062 – 2068DOI, Online Volltext (Open Access)
-
Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma – a case series of the ADF working group „cutaneous lymphomas”In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 12, 2014, Nr. 1, S. 39 – 46
-
Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHDIn: Bone Marrow Transplantation, Jg. 49, 2014, Nr. 6, S. 800 – 805
-
JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosisIn: Leukemia, Jg. 28, 2014, Nr. 8, S. 1736 – 1738
-
Allogeneic haematopoietic stem cell transplantation in a patient with cutaneous γ/δ-T-cell lymphomaIn: Acta Dermato-Venereologica, Jg. 93, 2013, Nr. 3, S. 360 – 361DOI (Open Access)
-
Bronchiolitis obliterans after allogeneic hematopoietic SCT : Further insight - New perspectives?In: Bone Marrow Transplantation, Jg. 48, 2013, Nr. 9, S. 1224 – 1229
-
Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantationIn: Bone Marrow Transplantation, Jg. 48, 2013, Nr. 5, S. 732 – 733
-
Long-term observation of thrombotic microangiopathies after haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 48, 2013, Nr. Suppl. 2, S. 352
-
Significantly delayed T-cell immune reconstitution under mycophenolate-containing triple immunosuppressive therapy after allogeneic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 48, 2013, Nr. Suppl. 2, S. S148 – S149
-
CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in LymphomaIn: Blood, Jg. 120, 2012, Nr. 21, S. 1635
-
CMV-replication after allogeneic stem cell transplantation is associated with a GVHD-independent reduced relapse risk in lymphomaIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 156
-
Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemiaIn: International Journal of Laboratory Hematology, Jg. 34, 2012, Nr. 1, S. e3 – e5
-
Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated DonorsIn: Blood, Jg. 120, 2012, Nr. 21, S. 4182
-
Different gene variants are associated with outcome of patients transplanted from HLA-identical unrelated donors compared to patients with sibling donorsIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. S165 – S166
-
Dynamic international prognostic scoring system scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosisIn: Haematologica, the hematology journal, Jg. 97, 2012, Nr. 10, S. 1574 – 1581DOI (Open Access)
-
Incidence and outcome of thrombotic microangiopathies after haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 197
-
Incidence and outcome of thrombotic microangiopathies after hematopoietic stem cell transplantationIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 211
-
Incidence, mortality and biological characteristics of Bronchiolitis obliterans after allogeneic haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 51
-
Incidence, mortality and biological characteristics of bronchiolitis obliterans (BO) after allogeneic haematopoietic stem cell transplantation (HSCT)In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 199 – 200
-
Jian-Jian Luan Award CMV-replication after allogeneic stem cell transplantation is associated with a GvHD-independent reduced relapse risk in lymphoma : evidence for a putative virus-versus-lymphoma effectIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 60
-
Only gene variants of IL10, IL23R and LCT 13910 influence transplant outcome of patients with HLA-identical unrelated donors as well as patients with sibling donorsIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 127
-
Outcome of allogeneic haematopoietic stem cell transplantation in patients with atypical chronic myeloid leukaemiaIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 428
-
Quantitative expression of Toll-like receptor-1,-2,-3,-5,-7, and-9 in blasts of patients with newly diagnosed or relapsed acute myeloid leukaemiaIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 113
-
Response : T cells are required for the CMV-induced antileukemia effect after transplantIn: Blood, Jg. 119, 2012, Nr. 4, S. 1090 – 1091
-
Significance of prognostic scores, risk factors and chronic graft-versus-host disease on outcome after allogeneic haematopoietic stem cell transplantation for myelofibrosisIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 433
-
T cells are required for the CMV-induced anti-leukemic effect in patients with acute myeloid leukemia patients after transplantIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 173
-
T-cells but not KIR ligand incompatibilities are required for the CMV-induced anti-leukaemic effect in patients with AML after transplantIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 71
-
The effect of low-energy laser therapy on oral chronic graft versus host diseaseIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 210
-
Chronic GvHD is the most pivotal factor for improved relapse-free survival in patients with myelofibrosis after myeloablative allogeneic haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 46, 2011, Nr. Suppl. 1, S. S362 – S362
-
Early CMV-replication after allogeneic stem cell transplantation is associated with a dramatically reduced relapse risk in acute myeloid leukemia patients : Evidence for a putative virus-versus-leukemia effectIn: Onkologie, Jg. 34 6, 2011, S. 297 – 297
-
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk : evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patientsIn: Blood, Jg. 118, 2011, Nr. 5, S. 1402 – 1412DOI (Open Access)
-
H1N1 in allogeneic stem cell recipients : Courses of infection and influence of vaccination on graft-versus-host-disease (GVHD)In: Annals of Hematology, Jg. 90, 2011, Nr. 1, S. 117 – 118
-
Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donorsIn: Bone Marrow Transplantation, Jg. 46, 2011, Nr. 5, S. 702 – 708DOI (Open Access)
-
No influence of gene polymorphism of LCT (C13910T) on transplantation outcomes in acute myeloid leukemia patients who received transplantations from HLA-identical sibling donorsIn: Blood, Jg. 115, 2010, Nr. 17, S. 3644 – 3645
-
Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantationIn: Histology and Histopathology, Jg. 22, 2007, Nr. 4, S. 365 – 372
-
Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation.In: Histology and Histopathology, Jg. 20, 2005, Nr. 3, S. 879 – 889
-
Impact of conditioning intensity on outcome in high-risk myelofibrosis undergoing allogeneic stem cell transplantation
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 58 – 59DOI (Open Access) -
Reduced Intensity Stem Cell Transplantation for Accelerated-Phase Myelofibrosis
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 314 – 315DOI (Open Access) -
CML Relapse after Allogeneic HSCT : Survival, Treatment Efficacy and Prognostic Factors for Outcome
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Suppl. 1, S. 275 – 276DOI (Open Access) -
Comparison of Immune Cell Response to Cytomegalovirus Proteins Versus Peptides using an IFN-γ Elispot Assay to Monitor cytomegalovirus-specific Immunity after Hematopoietic Stem Cell Transplantation
46th Annual Meeting of the European Society for Blood and Marrow Transplantation ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Supplement 1, S. 457 – 458DOI (Open Access) -
Fertility in Adult Female Allogeneic Stem Cell Recipients
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Suppl. 1, S. 149 – 150DOI (Open Access) -
Impact of CD34(+)-Stem Cell Boost on Outcome and Hematological Reconstitution in Patients with Severe Aplastic Anemia after Allogeneic Stem Cell Transplantation : A Retrospective Study
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Suppl. 1, S. 216 – 217DOI (Open Access) -
Impact of Mutation Profile in Chronic Myelomonocytic Leukemia undergoing Allogeneic Hematopoietic Cell Transplantation
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Suppl. 1, S. 570 – 571DOI (Open Access) -
Standardized Monitoring of cytomegalovirus-specific Cellular Immunity can Improve Risk Stratification of Recurrent Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation
46th Annual Meeting of the European Society for Blood and Marrow Transplantation ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Supplement 1, S. 470 – 471DOI (Open Access) -
CML relapse after allogeneic HSCT : survival, treatment efficacy and prognostic factors for outcome
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 218DOI (Open Access) -
Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation : Comparing Post-Transplant Cyclophosphamide Versus Anti-T-Lymphocyte Globulin As Graft-Versus-Host Disease Prophylaxis in a Retrospective Cohort Study
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1: 61st ASH Annual Meeting, S. 3289 – 3289DOI (Open Access) -
Long-term outcome after transplantation in patients with chronic myeloid leukemia from HLA-compatible unrelated donors
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 131DOI (Open Access) -
Outcome and reconstitution after allogeneic hematopoietic stem cell transplantation in patients with secondary myelofibrosis : a retrospective cohort study
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 283DOI (Open Access) -
Adoptive immunotherapy +/- Ruxolitinib and second allogeneic hematopoietic stem cell transplantation in patients with relapsed Myelofibrosis after allogeneic hematopoietic stem cell transplantation
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 60 – 61DOI (Open Access) -
Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in hematopoietic stem cell transplant recipients
The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation; Mar 18 - 21, 2018; Lisboa, Portugal,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 53, 2018, Nr. Supplement, S. 92 – 93 -
Comprehensive Clinical-Molecular Transplant Risk Model for Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 689 – 689DOI (Open Access) -
Impact of anti-Jurkat anti-thymocyte globuline on long-term outcome of Allogeneic matched unrelated donor hematopoietc cell transplantation in hematologic malignancies : A large single-center comparative analysis
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 151DOI (Open Access) -
Early Replication of Human Cytomegalovirus (HCMV) is associated with a reduced risk of hematologic relapse in myeloid neoplasias after matched Unrelated Stem Cell Transplantation (HSCT) in an anti-thymocyte-globuline dependent mannerIn: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 3, S. 312 – 313
-
Early CMV-replication after allogeneic stem cell transplantation is associated with a dramatically reduced relapse risk in acute myeloid leukaemia patients : evidence for a putative virus-versus-leukaemia effectIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. S56 – S57
-
Early cytomegalovirus replication after allogeneic stem cell transplantation is associated with a dramatically reduced relapse risk in acute myeloid leukemia patients : Evidence for a putative virus-versus-leukemia effectIn: Biology of Blood and Marrow Transplantation: Elsevier Health Sciences, Jg. 17, 2011, Nr. 2, Suppl., S. S161DOI (Open Access)
-
Improved outcome of transplant in patients with CMLIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. 361 – 362
-
Increased miRNA17 and miRNA20a expression in patients with development of acute Graft-versus-host disease after allogeneic stem cell transplantation
Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Onkologie Jahrestagung, Basel, September-Oktober 2011,In: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 278 -
Pravastatin after allogeneic haematopoietic stem cell transplantation : better tolerated than expected but without significant influence on chronic graft-versus-host diseaseIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46 1, 2011, Nr. Suppl. 1, S. S111 – S111
-
Results of simultaneous analysis of 48 gene variants reported to have influence on transplant outcomeIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. S66 – S67
-
Results of simultaneously performed analysis of 48 gene variants reported to have influence on transplant outcomeIn: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 229
-
Significance of prognostic scores, risk factors and chronic graft-versus-host-disease (cGVHD) on outcome after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosisIn: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 206 – 206
-
Improved outcome of transplant in patients with CML
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 84 -
Allogene Stammzelltransplantation bei primärer und sekundärer Philadelphia-Chromosom negativer MyelofibroseDuisburg, Essen, 2013
-
Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation : Results from the German Stem Cell Transplant Registry (DRST)
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1, S. 10563 – 10565DOI (Open Access)